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Despite the apparent success of several new cephalosporins in the treatment of
Gram-negative bacterial meningitis, four treatment failures with cefotaxime or
latamoxef were encountered (two caused by Enterobacter and two by Serratia spp.).
In-vitro parameters of susceptibility of these clinical isolates were compared with
those of a meningeal Ent. cloacae isolate from a successfully treated patient. The
MIC and MBC values, degrees of inoculum effect, and amounts of /?-lactamase
produced correlated poorly with the observed clinical outcome. However, the extent
to which an isolate was killed by the cephalosporin used for treatment, in a 6-h in-
vitro incubation, showed good correlation. We suggest that such a test should be
used to predict clinical outcome of therapy because the other parameters such as the
MIC and MBC values are not sufficiently discriminatory.
Introduction
The treatment of Gram-negative bacterial meningitis with several of the newer
cephalosporins (such as cefotaxime, ceftriaxone and latamoxef) has been highly
successful and documented in an extensive literature (Cherubin et al., 1982; Corrado,
Gombert & Cherubin, 1982; Cherubin & Eng, 1986). However, individual reports have
begun to appear describing treatment failures (Bradsher, 1982; Eng et al., 1984a).
Organisms responsible for failures have included susceptible strains of Escherichia coli,
Klebsiella pneumoniae and Salmonella spp. An earlier study showed that the failures
were possibly attributable to a lack of rapid bactericidal activity of the new
cephalosporins against the individual isolates of the patients (Eng et al., 1984a).
Whether such observations can be expanded to include other members of the
Enterobacteriaceae is not known.
In four treatment failures (two Enterobacter and two Serratia species) the pathogens
were available and were studied in vitro for killing activity of the cephalosporins
employed during treatment. The results were compared with those from a successful
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treatment of enterobacter meningitis. In addition, /J-lactamase production in these and
other control isolates was examined, to determine the importance of this in treatment
failure.
Materials and methods
Patients, bacterial isolates and antibiotics
The cases of Gram-negative bacterial meningitis were cases seen by the authors or
referred to them by other Infectious Disease physicians during the period 1978 to 1980.
Enterobacter cloacae EL 3513 was also included in the study. This organism was
obtained from the blood of a patient and, in a rabbit model of meningitis, had been
shown to be unresponsive to therapy by cefotaxime and latamoxef (Beam, 1983). A
collection of nonmeningeal isolates of Ent. cloacae was also included for pMactamase
studies.
Susceptibility testing
The bacterial isolates were tested for susceptibility to antibiotics in three ways. First,
the isolates were tested by macro-broth dilution method with an inoculum of
5 x 103 cfu/ml in 1 ml. Secondly, the method described by Eng, Smith & Cherubin
(19846) was used to ascertain the effect of a large inoculum (5 x 107 cfu/ml) on the
susceptibility results. Thirdly, the method of washing the bacteria free of antibiotic
before subculture was used to eliminate the antibiotic carry-over effect (Eng et al.,
1984a).
Killing kinetics
Killing curves were generated by exposing 5 x 105 or 5 x 107 cfu/ml bacteria in tubes
containing 5 ml Mueller-Hinton broth and multiples of the MICs of the test
antibiotics, as described by Eng et al. (1984a).
P-Lactamase studies
Bacteria were grown at 37°C in tryptic soy broth (Difco, Detroit, MI), with shaking at
300 rpm. Organisms were collected by centrifugation in late logarithmic phase, after
2-3 h growth, (l-2±0-4x 109 cfu/ml), and washed twice in 01 M saline. Bacteria (1 ml
pellet, or approximately 1 g wet weight) were resuspended in 5 ml saline and disrupted
by sonic treatment (Artek Sonic 300 at 60 W) by two 3-5 min bursts. The preparation
was maintained on ice during sonication. Cell debris was removed by centrifugation
at 48,000 g for 20 min at 4°C and supematants were decanted. /?-Lactamase activity in
the crude extract was quantified using a spectrophotometric assay at 483 nm in 0-1 M
phosphate buffer, pH 70 (Ultraspec 4050, LKB produkter AG, Broma, Sweden,
coupled with an Apple lie microcomputer) with nitrocefin (100 /iM final concentration)
as substrate. /?-Lactamase activities were standardized per mg of protein (BCA protein
assay Kontron, Zurich, Switzerland). The amount of /Mactamase produced by a strain
was given as the arithmetic mean of at least three completely independent
determinations.
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/?-Lactamase induction was assessed using an adaptation of the method of Gootz &
Sanders (1983), with cefoxitin, 10 mg/1 final concentration, as inducer. Controls,
without cefoxitin, were run simultaneously. Kinetic constants, K,,, and V ^ , , were
determined spectrophotometrically at 260 nm and 37°C after partial purification of the
crude extract on Sephacryl S 200 in 0 1 M Tris-HCl buffer (pH 7-5) at 4°C.
Cephaloridine was used as substrate, at concentrations varying from 001 to 0-2 mmol.
K^ and V ^ values were estimated from a least-squares fit to a Lineweaver-Burk plot.
Frequency of resistant clones
The frequency of resistant clones existing within the bacterial population before
exposure to /Mactam agents was estimated by enumerating the cfu on Mueller Hinton
agar containing cefotaxime at 32 times the MIC. The starting inoculum size was 1 0 to
2 0 x 108 cfu and the antibiotic agar plates were incubated for 24 h at 37°C.
Case studies
Case 1
This case has been previously reported by Corrado et al. (1982) and only the details of
therapy are summarized here. A 31 year-old man developed meningitis several days
after head trauma. Gram stain of his CSF revealed numerous Gram-negative bacteria.
He received 12 g cefotaxime per day. The organism was identified as Ent. aerogenes and
the MIC of cefotaxime was 006 mg/1 by microdilution and 0-3 mg/1 by macrobroth
dilution. The CFS cefotaxime levels ranged from 41 to 11-5 mg/1. The organism
persisted in the CSF during therapy and appeared on Gram stain as filamentous forms.
On days 2 and 3 of therapy, the same organism was isolated, with much higher MICs
and MBCs of both cefotaxime and latamoxef (0-3-2-5 mg/1). This necessitated the
addition of gentamicin 5 mg/kg/day intravenously and 8 mg/day intrathecally, plus
carbenicillin 500 mg/kg/day intravenously. The patient did not respond and died.
Case 2
A 57 year-old man developed Ent. cloacae meningitis 11 days after craniotomy for a
left cerebral haematoma. Latamoxef was administered as initial therapy (12 g day).
The initial MIC and MBC of the isolate were 0-3 and 4-8 mg/1, respectively, of
latamoxef and 0-8 and 1-5 mg/1, respectively, of cefotaxime. Repeat lumbar puncture
48 h later showed continued presence of the organism on Gram stain and cultures
yielded a more resistant strain. Cefotaxime was substituted for latamoxef at the same
dose. However, subsequent CSF bactericidal assays revealed no apparent killing
activity for the latter isolates. The resistant strain had MIC and MBC of 100 mg/1 for
both antibiotics. Latamoxef was readministered along with 5 mg/day gentamicin
intrathecally. The patient recovered after 14 days of combined therapy.
Case 3
A 32 year-old man was admitted following a motorcycle accident. CT scan showed
haemorrhage into the left maxillary sinus, and an intraventricular pressure monitoring
906 R. H. K. Eng et al.
device was inserted. On the fifth day, he developed deep coma and a temperature of
KMT. Lumbar puncture yielded CSF with 20 polymorphonuclear cells and
332 RBC/mm3. Protein was 48 mg/dl and glucose 72 mg/dl. A moderate number of
Gram-negative bacteria were seen per high power field, subsequently identified as
Ent. cloacae. The MIC of ceftriaxone was 0-2 mg/1. The patient was started on
ceftriaxone at 2 g 8 hourly.
The patient showed no clinical improvement for three days. Although the CSF was
sterile at this time, the CSF leucocyte cell count had increased to 11,400/mm3, On day
8 of therapy, a repeat lumbar puncture showed fluid with 103 WBC. The CSF
ceftriaxone level was 7 mg/1 and bactericidal activity was 1:1024. Progressive clinical
improvement was noted between days 8 and 10 and the patient recovered without
residua.
Case 4
A 57 year-old man had two surgical attempts at evacuation of a parietal hacmatoma
from arteriovenous malformation. Five days after the second operation, he developed
Ser. marcescens meningitis. He was treated initially with chloramphenicol, then with
intrathecal amikacin for two days, then with amikacin and concurrent iv latamoxef for
four days. His CSF remained culture-positive and he died. The initial isolate had MIC
and MBC of 0-3 and 1-25 mg/1 latamoxef, respectively.
Case 5
A 42 year-old developed Ser. marcescens meningitis after an evacuation of cerebral
haematoma sustained in a car accident. He was treated initially with penicillin and
chloramphenicol until the organism was identified. Intrathecal gentamicin and
12 g/day latamoxef were administered. CSF cultures remained positive after 14 days of
therapy. A variety of other antibiotics, including new cephalosporins, were added, but
the patient died.
Laboratory results
Susceptibility results
The MIC and MBC data are shown in Table I. The initial isolates from all the cases
showed similar MICs and MBCs for all the /Mactam antibiotics tested. The isolate
from the successfully treated case of Ent. cloacae meningitis (case 3) had MIC and
MBC values indistinguishable from those of initial isolates from the failure cases
caused by Enterobacter spp. (cases 1 and 2). The MBC values for the antibiotics used
in therapy were 1-5 mg/1 ceftriaxone for case 3 as against 2-5 and 1-2 mg/1 of
cefotaxime and latamoxef, respectively, for cases 1 and 2. Subsequent isolates from the
failure cases caused by Enterobacter spp. were far more resistant.
The MBC values were noted to depend on the methods used. The values obtained by
the standard method are shown in Table I. These values of isolates from failure cases
did not differ from the value of a successfully treated case. A comparison of washing
versus not washing df the organisms on Millipore filters prior to subculture showed
major differences in several antibiotic-bacteria combinations. A prime example of this
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Table I. Summary of antibiotic susceptibility of meningeal isolates'
Isolate
Case 1
Ent. aerogenes
initial
subsequent
Case2
Ent. cloacae
initial
subsequent
Case3
Ent. cloacae
Case 4
Ser. marcescens
Case5
Ser. marcescens
EL 3513
Ent. cloacae
CTX
0-3/2-5
(8)
400/ > 400
( - )
0-6/1-2
(64)
100/> 100
( - )
0-3/1-2
(2)
0-3/> 20
(64)
0-6/1-2
(64)
0-3/5-0
(2)
MIC/MBC
LMX
0-3/2-5
(4)
200/200
( - )
0-3/5-0
(2)
10-0/> 100
( - )
1-2/2-5
(16)
0-3/1-2
(2)
0-3/>5
(>32)
0-3/0-3
(8)
CTR
0-7/0-7
(2)
0-7/6-0
(32)
10-0/> 100
( - )
0-2/1-2
(8)
0-3/0-3
(2)
0-6/0-6
(4)
1-5/3-0
(8)
IMP
0-6/1-2
(4)
0-3/0-3
(1)
1-2/2-5
(4)
1-2/2-5
(4)
0-6/2-5
(8)
2-5/5-0
(4)
1-2/2-5
(2)
1-5/1-5
(2)
•CTX, Cefotaxime; LMX, latamoxef; CTR, ceftriaxone; IMP, imipenem.
Inoculum effect in parenthesis is expressed as tbe ratio of the MIC for 5 x 107 cfu/ml to the MIC for
5xlO'cfu/ml.
was the isolate from case 1. After a 6 h exposure to cefotaxime at 32 x MIC, there was
less than a 1-log cfu reduction, but when the organisms were not washed free of the
antibiotic a reading of a greater than 3-log reduction was recorded (Figure 1).
The MICs of cefotaxime, latamoxef and ceftriaxone for the isolates when the
inoculum size was raised from 5 x 103 to 5 x 107 exhibited a two-fold to greater than
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Figure 1. Difference in 6 h bactericidal results when the organisms of the isolate from Case 1 were washed
(O) and unwashed (A) before subculture.
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Figure 2. Number of bacteria killed in 6 b (open bars) and in 18 h (hatched bars) by 4 x MIC of the
cephalosporin used in treatment of the meningeal isolates or of EL 3513 (the meningitis animal model
strain). Antibiotic abbreviations: see Table I.
32-fold increase. Imipenem did show a slight inoculum effect, but an inoculum effect of
greater than eight-fold was not noted with this agent.
Susceptibility of isolates to fi-lactam killing
The log decreases in cfu/ml of each isolate when exposed to 4 x MIC of the antibiotic
used in treatment are shown in Figure 2. The major distinguishing feature of the
isolate from the successfully treated case (case 3) from the antibiotic failure cases was
the amount of killing attained at 6 h of incubation. The isolate from case 3 attained a
31 log reduction in cfu/ml in 6 h whereas other isolates showed a considerably smaller
amount of killing.
4 8
Multiple! of MIC
16 32
Figure 3. Concentration-dependent killing of meningeal isolates at 6 h by the cephalosporin used in
treatment (case 1, cefotaxirne, O; case 2, latamoxef. A; case 3, ceftriaxone, D; case 4, latamoxef, A; and
case S, latanioxef, # ) . The experiments were performed with washing of the bacteria free of antibiotics prior
to quantitative subculture.
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When the antibiotic concentrations were increased in the killing kinetic studies,
while antibiotic carry-over was eliminated by washing, isolates from cases 4 and 5 were
totally resistant to killing by cefotaxime and latamoxef, as were the Enterobacter
isolates recovered during therapy from cases 1 and 2. In contrast, the isolate from the
successfully treated case showed concentration-dependent killing (Figure 3).
P-Lactamase production by the isolates
/J-Lactamase production before and after cefoxitin induction in these isolates is shown
in Table II. For the Enterobacter isolates initially recovered from cases 1 and 2, the
amount of /Mactamase produced was 002 and 0-1 units as compared to 002 unit from
case 3 (success case). After induction by cefoxitin, the units of enzymes from the
isolates of cases 1 and 2 were 0-3 and 0-2, respectively as compared with 0-13 for
case 3. Hence the amount of /Mactamase produced by the organism with and without
cefoxitin induction did not distinguish among the isolates with regard to success or
failure during treatment with stable /Mactam antibiotics. The kinetic parameters, Km
and V ^ , were all characterized by low K,,,, indicating a very high affinity of the /?-
Table II. Summary of /Mactamase studies
Isolate
Enterobacter
Case 1
first
second
Case2
first
second
Case3
EL 3513
1228
688
1483
1394
1201
692
362
1529
4207
66
288
Serratia
Case4
Case5
/7-Lactamase
Without
induction"
(S.D.)
002 (001)
0-3 (01)
01 (001)
01 (0-01)
002 (001)
002 (001)
001 (0005)
0-03 (0-01)
1-51 (0-2)
401 (0-3)
4-79 (0-3)
002 (0005)
001 (0005)
002 (001)
001 (0005)
001 (0005)
001 (0005)
015(001)
012 (001)
activity
Induction
ratio*
15
4-7
2
7
6-5
9-5
123
109
4-6
4
116
10 5
4
96
15
28
8
5-3
5-8
Kinetic
K»
0-4
0-2
0-3
0-3
0-9
0-2
0-36
2-9
012
ND
019
0-73
0-37
ND
0-2
ND
3-0
0-9
0-3
values'
1
14
0-7
19
0-8
11
10
60
10
ND
11
0-7
008
ND
0-5
ND
30
7-3
20
Frequency of
clones resistant
to CTX at
32 x MIC
2 x l O " 6
1 x l O ' 6
<1 x l O " 8
3 x l O " 7
< l x l 0 - »
"Activity expressed in //mol/min/mg of protein.
'Ratio of activity following induction with 10 mg/1 cefoxitin to the uninduced level.
CKO is expressed in ptmol and V ^ in ponol/min/mg protein.
ND, Not determined.
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lactamase for the substrate. However, these parameters were similar for all the isolates
studies, including the nonmeningeal isolates.
The organism isolated from patient 1 during treatment produced 15 times more (i-
lactamase than the pretreatment isolate. Also, with cefoxitin stimulation, the treatment
isolate produced four times more /Mactamase than the pretreatment isolate. For
case 2, the second isolate showed a three fold increase in /Mactamase production in the
presence of cefoxitin as compared to the pretreatment isolate. ^-Lactamase induction
by cefoxitin appeared to be more pronounced in those organisms isolated during
therapy.
Frequency of resistant clones
The frequencies of clones resistant to 32 times the MIC for cefotaxime are shown in
the last column of Table II. These frequencies ranged between less than 10"8 to
2 x 10~6, with the lowest frequencies found in the organisms from cases 3 and 5.
Discussion
Bacterial meningitis is a rapidly fatal disease and host defences in the CSF are limited.
To a large extent, the patient is dependent upon the bactericidal activity of antibiotics
to eradicate the organisms. Gram-negative organisms have presented a therapeutic
problem because many older antibiotics were ineffective in vitro and in vivo. The use of
the new cephalosporins appears to be associated with increased survival rates.
However, cases of Gram-negative meningitis have been reported in which treatment
with the new cephalosporins was associated with failure (Bradsher, 1982; Eng et al.,
1984a).
The success of the new cephalosporins was initially attributed to potent activity as
reflected in low MIC values. Closer examination of the susceptibility information with
respect to clinical responses has shown that low MIC values are necessary, but by no
means can be used as a universal predictors of treatment success of Esch. coli and
K. pneumoniae meningitis. In these two species, it is unlikely that /Mactamases play a
significant role in causing treatment failure. With Serratia and Enterobacter spp.,
however, treatment failures of nonmeningeal sites have been ascribed to the large
amount of /Mactamases produced or induced. We have examined the in-vitro
parameters of susceptibility to find the parameter that best predicts success of therapy.
The amount of /Mactamases produced, and induced in Cases 1 and 2 did not differ
greatly from that of the other Enterobacter isolates tested. Isolates recovered during
therapy and which had become resistant showed markedly greater production of /?-
lactamase than the initial isolates from the same patient and, in general, the
production rate is also greater than those isolates recovered from nonmeningeal sites.
The amount of /Mactamase produced in the presence or absence of cefoxitin did not
greatly differ between any of the groups of organisms. The frequency of resistant
clones within the bacterial population of the pretreatment isolates was clearly different
between the enterobacter failure and success cases. However, very low frequencies were
also found among the isolates from the two serratia failure cases. The MIC values are
clearly not sufficient in themselves to predict the success or failure of a treatment
regimen, and the MBC results may be falsely low, unless the organisms are washed free
of the test antibiotics before subculture. Yet, even with the addition of this washing
step in the MBC methodology, the MBC values obtained from 18 to 24 h incubation
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in themselves were not sufficiently discriminatory to predict the success of therapy.
Inoculum effect of the treatment antibiotic-isolate combinations also failed to
discriminate between combinations that produced clinical success or failure.
On the other hand, the bactericidal effect at 6 h correlated well with clinical
response. The isolate that showed a 3-log or more decrease following 6-h incubation
with antibiotic concentrations up to 16 x MIC was associated with success of therapy.
Conversely, those bacterium-antibiotic combinations which did not produce a rapid
decrease in cfu were associated with a poor clinical response. The 6 h bactericidal test
is not difficult to perform and can be completed within one day in the microbiology
laboratory; results can be available the next day. In fact, this test would require no
more time for completion than the standard MBC test.
Our data are limited by the small number of cases we were able to collect. Our
observation should be extended by infectious disease clinicians who treat such patients.
If our conclusions can be upheld, bactericidal kinetics during the first 6 h of incubation
could become a better test in the evaluation of antibiotics for treatment of Gram-
negative bacterial meningitis.
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